U.S. market Closed. Opens in 3 hours 54 minutes

VAXX | Vaxxinity, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/A66.00K557.00KN/A
Cost of Revenue2.23M1.68M1.94M52.00K107.00K
Gross Profit-2.23M-1.68M-1.87M505.00K-107.00K
Operating Expenses56.05M75.98M123.20M32.79M13.66M
Selling, General & Admin22.39M28.35M51.83M12.22M3.00M
Research & Development33.66M47.63M71.38M20.57M10.66M
Other Operating ExpensesN/AN/A-8.37M-5.76M-27.00K
Operating Income-58.28M-75.98M-125.08M-32.28M-13.66M
Other Expenses / Income58.23M757.00K-12.10M-7.67M-502.00K
Before Tax Income-56.93K-75.22M-137.18M-39.96M-14.16M
Income Tax Expenses-56.93K-12.00K840.00K-4.58M56.00K
Net Income-56.93K-75.21M-138.01M-35.38M-14.22M
Interest Expenses696.00K514.00K840.00K1.18M435.00K
Basic Shares Outstanding126.51K125.94M125.39M125.45M125.45M
Diluted Shares Outstanding126.51K125.94M125.39M125.45M125.45M
EBITDA-56.05K-74.30M-135.23M-31.57M-13.58M
EBITDA Margin0.00%0.00%-204,898.48%-5,666.97%0.00%
EBIT582.13K-74.71M-136.34M-38.78M-13.73M
EBIT Margin0.00%0.00%-206,568.18%-6,961.58%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙